magicmed

This Week in Psychedelics - 1.29.21

ThisWeekinPsychedelics.png

Cannabis

  • Arizona: Adult Use Marijuana Sales Begin (NORML)

  • 2 Years After Legalizing Cannabis, Has Canada Kept Its Promises? (The New York Times)

  • Alabama Could Legalize Medical Marijuana Under Bill Filed By Republican Senator (Marijuana Moment)

  • CBD Destroys Antibiotic-Resistant Bacteria Such as Gonorrhea, Study Finds (VICE)

  • Chuck Schumer Lists Marijuana As A Priority In First Post-Election Cannabis Comments (Marijuana Moment)

  • Anti-Marijuana Lawmaker Files Legalization Bill In North Dakota To Avoid Activist Ballot Measure (Marijuana Moment)

  • Areas With More Marijuana Dispensaries Have Fewer Opioid Deaths, New Study Finds (Marijuana Moment)

  • Opioid Prescriptions Decline in Canada Following Enactment of Adult-Use Marijuana Legalization (NORML)

  • Transition From Trump To Biden Impacts Federal Hemp And CBD Rules (Marijuana Moment)

  • Michigan testing labs sound warning about contaminated cannabis (Marijuana Business Daily)

  • Bill To Allow Medical Marijuana Use At Hotels And Airbnbs Filed In Missouri (Marijuana Moment)

LSD

  • LSD breakthrough could enable treatment for autism and social anxiety, research finds (Sky News)

Magic Mushrooms

  • Hawaii Could Legalize Psychedelic Mushroom Therapy Under New Senate Bill (Marijuana Moment)

  • Kevin Matthews Wants to Decriminalize Mushrooms Across Colorado (Westword)

  • Port Townsend woman seeks decriminalization of ‘magic’ mushrooms (Peninsula Daily News)

  • UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition (Psilocybin Alpha)

  • Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility (Psilocybin Alpha)

  • Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland (Psilocybin Alpha)

  • MagicMed Files For Psilocybin Derived Patents (Green Market Report)

  • Is America Ready For Psilocybin Mushroom Retreats? (Benzinga)

MDMA

  • Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon (The Conversation)

DMT

Ayahuasca

  • Ayahuasca, Severe Illnesses, and the Mystery of Death (Chacruna)

  • Woman, 29, killed herself after ‘suffering psychosis from taking hallucinogenic yoga drugs on spiritual retreat’ (The Sun)

  • Ayahuasca’s Role in the Entourage Effect and Depression (Psychedelic Science Review)

  • An Ayahuasca Retreat Brings Powerful Changes (Healing Maps)

Peyote

  • Let’s Talk About Hikuri: A Peyote Conservation Project by the Wixárika (Chacruna)

Iboga

  • How the psychedelic Ibogaine helped a retired Vancouver firefighter treat his depression (The GrowthOp)

Novel Psychoactive Substances

  • BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies (Psilocybin Alpha)

Ketamine

  • Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression (Psilocybin Alpha)

  • Ketamine to treat depression and addiction at UK’s first medical psychedelic psychotherapy clinic (iNews)

  • Users of ketamine at significantly higher risk of suicide: study (Focus Taiwan)

  • A Wall Street banker who made millions in the dot com boom dropped it all to become a 'psychedelics concierge' to the stars. Now he wants everyone to have access to ketamine. (Insider)

  • How to Know if Ketamine Therapy Is Right for You (Santa Clarita Magazine)

DXM

  • Low-dose dextromethorphan for the treatment of fibromyalgia pain: results from a longitudinal, single-blind, placebo-controlled pilot trial (MD Linx)

Miscellaneous

  • New Psychedelics Reform Group Sets Sights On Congress As Movement Builds (Marijuana Moment)

  • Atlanta: Mayor Takes Executive Action Abolishing Pre-Employment Drug Screens for Many Public Employees (NORML)

  • The Latest on Psychedelics for Treating Dementia (Psychedelic Science Review)

  • The world's first psychedelic ETF debuts (Yahoo! Finance)

  • Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US (Psilocybin Alpha)

  • The Cop Who Busted the Beatles Now Wants to Legalise All Drugs (VICE)

  • When The Giants Of Indian Classical Music Collided With Psychedelic San Francisco (NPR)

  • Mydecine Innovations Group Files Application to list to the NASDAQ (Psilocybin Alpha)

  • Biden Ending Federal Contracts With Private Prisons; Private ICE Detention Continues (Filter)

  • 5 Athletes Who Healed With Psychedelic Therapy (Benzinga)

  • “A ‘Dose’ of Radical Christianity”: Psychedelic Therapy with Dr. Florence Nichols (Chacruna)

  • atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents (Psilocybin Alpha)

  • Ohio Students Launch Harm Reduction and “Bad Batch” Alerts App (Filter)

  • Taking Psychedelics When You’re Not Feeling Good (Maps of the Mind)

  • In Brazil, Bolsonaro Continues to Pump Blood to the War on Drugs (TalkingDrugs)

  • Inside The Underground World Of Online Psychedelic Support Groups (Benzinga)

  • MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category (Psilocybin Alpha)

  • How to Start a Career in the Field of Psychedelic Integration (The Third Wave)

  • Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market (Psilocybin Alpha)

  • Mental Health Issues That Don't Mix Well With Psychedelics (Healing Maps)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.